Acambis PLC - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Acambis PLC. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Acambis PLC. The Group's principal activity is researching, developing and manufacturing vaccines to prevent and treat infectious diseases. The Group's vaccine product are ChimeriVax-JE and ChimeriVax-West Nile. ChimeriVax-JE is a single-dose vaccine for travellers and those living in endemic regions. ChimeriVax-West Nile focuses on viruses transmitted to humans and animals by the bite of an infected mosquito. The Group's other pipeline products are Clostridium difficile and Influenza vaccine. The Group operates in the United Kingdom and the United States of America.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report